by Artificial insemination involves insertion of sperm into the uterus or cervix for conception. This technique is commonly used for infertility treatment when sperm cannot reach and fertilize the egg. It has advantages over natural conception as it allows using sperm from a donor for single or same-sex couples. The increasing prevalence of infertility due to factors such as obesity, stress, sexually transmitted diseases and environmental pollutants is driving the demand for artificial insemination.
The global Artificial Insemination Market is estimated to be valued at US$ 10.6 Mn in 2024 and is expected to exhibit a CAGR of 8.1% over the forecast period 2024-2031, as highlighted in a new report published by Coherent Market Insights.
Market key trends
Intrauterine insemination (IUI) is gaining popularity over traditional artificial insemination as it directly deposits processed and prepared sperm into the uterus. This improves the chances of conception compared to depositing sperm in the vagina or cervical canal. The rising adoption of IUI procedures is expected to drive the artificial insemination market during the forecast period.
SWOT Analysis
Strength: Artificial insemination provides greater access to parenthood for single individuals and same-sex couples. It helps overcome fertility issues for many couples.
Weakness: It may cause psychological stress and relationship issues if not performed with proper counseling. Success rates are not guaranteed and multiple cycles may be required.
Opportunity: Rising infertility rates due to late parenthood, lifestyle diseases and environmental factors are increasing the demand for assisted reproductive technologies. Developing markets offer high growth potential.
Threats: Ethical concerns around the process may hamper social acceptance in some cultures. Stringent regulations can restrict market growth. Competition from alternate fertility treatments affects market share.
Key Takeaways
The global Artificial Insemination Market Demand is expected to witness high growth over the forecast period of 2024 to 2031. The global Artificial Insemination Market is estimated to be valued at US$ 10.6 Mn in 2024 and is expected to exhibit a CAGR of 8.1% over the forecast period 2024-2031.
Regional analysis: North America currently dominates the market due to rising rates of infertility and favourable reimbursement policies. The Asia Pacific region is expected to grow the fastest owing to large patient population, increasing medical tourism and growing public awareness. Countries like India, China and Japan are emerging as major markets.
Key players: The key players operating in the artificial insemination market are Pride Angel, Irvine Scientific, Hi-Tech Solutions, Rinovum Women’s Health, LLC, TenderNeeds Fertility, Conceivex, Inc., Labotech GmbH, Hamilton Throne Ltd., Biogenics Inc., Nikon Instruments Inc., Zander scientific Inc., and Surelife Pte Ltd. These players are focusing on new product launches, geographical expansions and strategic collaborations to gain market share.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
